When to Check Your Labs If youre starting tirzepatide with an abnormal baseline lipid panel, most providers recommend rechecking at three to four months into treatment, after youve had time to reach a meaningful dose and see early weight loss
Sublingual : Marketed but evidence is thin
Cytokine Modulation Pro-inflammatory cytokines like TNF-alpha, IL-6, and IL-1beta drive the inflammatory cascade that causes pain, swelling, and tissue damage
Its difficult to distinguish direct anti-inflammatory effects from the benefits of weight loss and improved metabolic health, but the pattern is consistent enough to warrant further study. A 2025 study found that RA patients with a BMI over 27 taking GLP-1 medications showed improvements in symptoms and disease activity
(PubMed) Bartels GL, Remme WJ, Pillay M, Schonfeld DH, Kruijssen DA
Next-generation molecules Newer molecules entering the GLP-1 space, including GLP-3 peptides , mazdutide , survodutide , and orforglipron , each have unique pharmacokinetic profiles that will require their own timing optimization strategies